FNWA
TGTX icon

Financial Network Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

Financial Network Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79K Buy
69
+4
+6% +$164 ﹤0.01% 594
2026
Q1 		$2.16K Buy
65
+7
+12% +$209 ﹤0.01% 654
2025
Q4 		$1.73K Buy
+58
New +$1.89K ﹤0.01% 705

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Financial Network Wealth Advisors's TGTX Position: Q2 2026 in Review

Financial Network Wealth Advisors increased its TG Therapeutics (TGTX) stake by 6.2% in Q2 2026, buying an estimated $164 and bringing the position to 69 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

Financial Network Wealth Advisors first reported a position in TGTX in Q4 2025 and has held it in 3 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Financial Network Wealth Advisors held 69 shares of TG Therapeutics worth $3.79K as of Q2 2026.
  • Financial Network Wealth Advisors bought 4 TG Therapeutics shares in Q2 2026, an estimated $164.
  • TG Therapeutics made up ﹤0.01% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #594 holding.
  • Financial Network Wealth Advisors first reported a position in TG Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.